"Endometrial Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.
| Descriptor ID |
D016889
|
| MeSH Number(s) |
C04.588.945.418.948.585 C13.351.500.852.762.200 C13.351.937.418.875.200
|
| Concept/Terms |
Endometrial Neoplasms- Endometrial Neoplasms
- Endometrial Neoplasm
- Neoplasm, Endometrial
- Neoplasms, Endometrial
Endometrial Carcinoma- Endometrial Carcinoma
- Carcinoma, Endometrial
- Carcinomas, Endometrial
- Endometrial Carcinomas
- Endometrial Cancer
- Cancer, Endometrial
- Cancers, Endometrial
- Endometrial Cancers
- Endometrium Cancer
- Cancer, Endometrium
- Cancers, Endometrium
- Cancer of the Endometrium
- Carcinoma of Endometrium
- Endometrium Carcinoma
- Endometrium Carcinomas
- Cancer of Endometrium
- Endometrium Cancers
|
Below are MeSH descriptors whose meaning is more general than "Endometrial Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Endometrial Neoplasms".
This graph shows the total number of publications written about "Endometrial Neoplasms" by people in this website by year, and whether "Endometrial Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 6 | 1 | 7 |
| 1995 | 10 | 0 | 10 |
| 1996 | 6 | 3 | 9 |
| 1997 | 5 | 2 | 7 |
| 1998 | 2 | 4 | 6 |
| 1999 | 3 | 0 | 3 |
| 2000 | 2 | 3 | 5 |
| 2001 | 2 | 1 | 3 |
| 2002 | 3 | 0 | 3 |
| 2003 | 12 | 5 | 17 |
| 2004 | 11 | 2 | 13 |
| 2005 | 17 | 3 | 20 |
| 2006 | 20 | 4 | 24 |
| 2007 | 15 | 1 | 16 |
| 2008 | 17 | 1 | 18 |
| 2009 | 23 | 2 | 25 |
| 2010 | 24 | 3 | 27 |
| 2011 | 17 | 1 | 18 |
| 2012 | 20 | 2 | 22 |
| 2013 | 41 | 4 | 45 |
| 2014 | 27 | 2 | 29 |
| 2015 | 37 | 3 | 40 |
| 2016 | 31 | 4 | 35 |
| 2017 | 24 | 3 | 27 |
| 2018 | 16 | 2 | 18 |
| 2019 | 38 | 0 | 38 |
| 2020 | 29 | 7 | 36 |
| 2021 | 19 | 0 | 19 |
| 2022 | 18 | 0 | 18 |
| 2023 | 37 | 1 | 38 |
| 2024 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Endometrial Neoplasms" by people in Profiles.
-
EphA2- and HDAC-Targeted Combination Therapy in Endometrial Cancer. Int J Mol Sci. 2024 Jan 20; 25(2).
-
Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146. J Immunother Cancer. 2024 01 19; 12(1).
-
Normal Risk Ovarian Screening Study: 21-Year Update. J Clin Oncol. 2024 Apr 01; 42(10):1102-1109.
-
Obesity is associated with improved progression-free survival in Microsatellite-Instability-High endometrial cancer treated with pembrolizumab. Gynecol Oncol. 2024 Jan; 180:139-145.
-
Path to Precision: Refining Radiation Therapy Guidelines for Early Stage Endometrial Cancer Through Incorporation of Primary Tumor Size, Lower Uterine Segment Invasion, and Molecular Markers. Pract Radiat Oncol. 2024 Mar-Apr; 14(2):154-160.
-
Combination of hormonal-based therapy in endometrial cancer: ready for prime time. Int J Gynecol Cancer. 2023 11 06; 33(11):1682-1683.
-
Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome. Clin Cancer Res. 2023 11 01; 29(21):4361-4372.
-
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial. J Clin Oncol. 2024 Jan 20; 42(3):283-299.
-
Isolated vaginal recurrence in women with stage I endometrial cancer. Gynecol Oncol. 2023 Dec; 179:9-15.
-
Post-Menopausal Bleeding: Role of Imaging. Semin Ultrasound CT MR. 2023 Dec; 44(6):519-527.